International Perfusion Association’s Post

This study examines hybrid coronary revascularization (HCR), a treatment combining minimally invasive coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) for multivessel coronary artery disease (MV CAD). It involved 138 patients who underwent either MIDCAB or MICS-CABG, with a median follow-up of 11 years. Results showed a 36.7% #CoronaryBypassSurgery #Hybrid #MinimallyInvasive #OffPump

📢 Title"Working Around: The Use of AngioVac and Micra Transcatheter Leadless Pacemaker Implantation in a Critically Ill Patient Receiving Extracorporeal Membrane Oxygenation" 🔓 #OpenAccess  🤵Authors: Ryan Morse, Mark Joseph, MD FACS FACC of Virginia Tech Carilion School of Medicine 🔔 Full Text: https://lnkd.in/gwjXi4jE  🔑 Keywords: ECMO, AngioVac, COVID-19, pacemaker, thrombus, ESRD #cardiac #surgery #cardiovascular #clinical #thoracic 😎Welcome to your reading!

I didn't knew this paper 🤔 My take home message📨: In glass 3 or WiFi stage 4 Go for a good gsv bypass, the shorter the better. This is why I am an advocate for diagnostic only angiograms. When you can treat the patient during the diagnostic exam, you will end up in endovascular intervention or at least an attempt. Spending time, money and sometimes arterial capital. Of course there is the access to treatment issue. After having a diagnostic angiogram, in some places, there isn't the availability of vascular surgeons that are able to perform bellow the knee or ankle bypass. But that is something to be addressed by the ones responsible for caring for this patients. Unfortunately some patients don't have arteries compatible with a bypass, or don't have a proper conduit. In those cases, endovascular interventionalists will have the possibility to save a limb. And we need better and better materials to make those interventions last, and of course properly trained interventionalists. But who is a properly trained interventionalist? ESVS Society Society for Vascular Surgery European Society of Cardiology American Heart Association

📢 New Review Published! We are excited to share the review: "Incidence, etiology, and outcomes of pre- and post-operative atrial fibrillation in mitral valve procedures" #Cardiology #CardioMed #CardiovascularDisease #Vascular #MedEd 🔍 Key Insights: Incidence: Atrial fibrillation (AF) is prevalent in patients undergoing mitral valve surgeries, with significant impacts on clinical outcomes. Etiology: Identifying the underlying mechanisms of both pre- and post-operative AF is critical for effective prevention and treatment strategies. Outcomes: Pre-operative AF is associated with poorer long-term survival, while post-operative AF increases short-term complications, emphasizing the importance of personalized management approaches. #AtrialFibrillation #MitralValve #CardiovascularHealth #MedicalResearch #HeartSurgery #PatientCare #LinkedInResearch 💡 This review is a valuable resource for cardiovascular surgeons, cardiologists, and healthcare professionals interested in optimizing care for mitral valve patients. 📖 Read more here: https://lnkd.in/gZAV57AA Let's discuss how these findings can shape future strategies in AF management! Afshin Ehsan, MD, MBA, FACS, Ray Griffith, Tawseef Ahmad Dar, MD, FACC, RPVI, Devon Dunlap, Laurie Mapes, Tommaso Hinna Danesi, Anna Snell, Ph.D., Greg Taussig, Yury Malyshev, Rakesh M. Suri, MD, DPhil

We’re proud to share that our study, “Impact of Systematic Diabetes Screening on Peri-Operative Infections in Cardiac Surgery,” is published in Scientific Reports - Nature! A Multidisciplinary Effort: Led by a team of endocrinologists,cardiac surgeons, and infection specialists, this work shows: • Routine HbA1c screening and diabetes management cut perioperative infections significantly. • 12% of patients had undiagnosed diabetes, allowing timely intervention. This highlights the power of collaboration to improve outcomes in cardiac surgery! Thank you Alessandro Mattina ! #upmc #infectioncontrol #teamwork #ismett

#828 A 68-year-old man with a history of myocardial infarction is scheduled for elective hernia repair. Which of the following statements regarding perioperative medication use in coronary disease patients undergoing noncardiac surgery is TRUE? A. Cardiac adverse event rates are reduced when high-dose beta-blocker therapy is initiated immediately before surgery B. Nitrates decrease intraoperative myocardial ischemia and reduce rates of adverse cardiac outcomes C. Most cardiac medications should be discontinued 2 to 3 days before surgery and resumed as soon as the patient can tolerate oral intake. D. Statin therapy has been associated with reduced perioperative cardiovascular event rates in high-risk patients. Answer =D It is generally safe and appropriate to continue most chronically administered cardiac medications up to the day of surgery and to resume them as soon as possible after the operation. This is true of beta-blockers in patients with underlying coronary artery disease (or other indications for chronic beta-blocker use) .However, there has been controversy about the role of initiating preoperative beta-blocker therapy for the purpose of risk reduction, as summarized in a recent systemic review. The evidence to date suggests that beta-blockers reduce the perioperative risk of cardiac events (ischemia, atrial fibrillation, need for coronary interventions), but can be associated with bradycardia, hypotension, and stroke, particularly if high doses or long- acting preparations are initiated shortly before surgery.If initiation of preoperative beta-blocker therapy is planned, it should be started at least 2-7 days before surgery, to assess tolerability and safety, and to allow titration of the dosage if appropriate. Although nitrates reduce intraoperative ischemia, cardiac outcomes are not affected. Statins have anti-inflammatory and plaque-stabilizing properties, and studies in patients undergoing vascular surgery have demonstrated reduced cardiac event rates in patients on such therapy perioperatively. #cardiology

HEMOTHORAX: A hemothorax (derived from hemo- [blood] + thorax [chest], plural hemothoraces) is an accumulation of blood within the pleural cavity. The symptoms of a hemothorax may include chest pain and difficulty breathing, while the clinical signs may include reduced breath sounds on the affected side and a rapid heart rate. Hemothoraces are usually caused by an injury, but they may occur spontaneously due to cancer invading the pleural cavity, as a result of a blood clotting disorder, as an unusual manifestation of endometriosis, in response to pneumothorax, or rarely in association with other conditions.Hemothoraces are usually diagnosed using a chest X-ray, but they can be identified using other forms of imaging including ultrasound, a CT scan, or an MRI. They can be differentiated from other forms of fluid within the pleural cavity by analysing a sample of the fluid, and are defined as having a hematocrit of greater than 50% that of the person's blood. Hemothoraces may be treated by draining the blood using a chest tube. Surgery may be required if the bleeding continues. If treated, the prognosis is usually good. Complications of a hemothorax include infection within the pleural cavity and the formation of scar tissue. Specialty Pulmonology Symptoms Chest pain Difficulty breathing Complications Empyema Fibrothorax Types Traumatic Spontaneous Causes Trauma Cancer Endometriosis Diagnostic method Chest X-ray Ultrasound CT scan MRI Thoracentesis Treatment Tube thoracostomy Thoracotomy Fibrinolytic therapy Medication Streptokinase Urokinase Prognosis Favorable with treatment Frequency 300,000 cases in the US per year #snscollegeofphysiotherapy #snsinstituitions #snsdesignthinkers #haemothorax #RLD #lungdisease

Excited to share European Association of Neurosurgical Societies (EANS) Spondylodiscitis Study Group’s latest publication in The Spine Journal, tackling a critical question Santhosh G. Thava Hariharan Subbiah Ponniah: ⚡ When to Operate in Critically Ill Spondylodiscitis Patients? This international multicenter study across 24 European centers analyzed 192 critically ill patients with severe pyogenic spondylodiscitis. Key Findings: • Optimal Timing: Delayed surgery (10–14 days post-admission) led to the lowest 30-day mortality (4.05%). • Higher Mortality: Early surgery and conservative therapy had significantly higher mortality rates (27.85% and 27.78%, respectively). • Reduced ICU/Hospital Stays: Delayed surgery reduced recovery time compared to other treatments. • Risk Factors: Advanced age, multiple organ failure, and vertebral body destruction. • Protective Factors: Delayed surgery and the presence of epidural abscess. A huge thank you to our incredible team for this impactful work! 📄 Read the full paper here: http://bit.ly/49CELN0

Transcatheter aortic valve replacement (TAVR) can be performed safely in adults with congenital heart disease (CHD) if done by a multidisciplinary team of specialists at a high-volume center, so concludes a Cleveland Clinic case series. TAVR can be an effective intervention in CHD in select clinical scenarios, proving both feasible & safe with good short-term outcomes. In high surgical risk, it can be used as a bridge to recovery, future surgery, transplantation, or palliation. Joanna Ghobrial Tara Karamlou Grant Reed https://lnkd.in/gMXUfMdj

Left Atrial-Veno Arterial Extracorporeal Membrane Oxygenation as a Bridge to Surgery for Endocarditis-Related Acute Severe Aortic Regurgitation